Fig. 6From: Baseline and recurrent exposure to the standard dose of artemisinin-based combination therapies (ACTs) induces oxidative stress and liver damage in mice (BALB/c)Liver Histology section (× 400; H & E) of mice treated with distilled water (control) (CTL) artemether/lumefantrine (A/L) or artesunate/amodiaquine (A/A) after the (A) first and (B) second exposure periods. Congestion of blood vessels (arrow) and degeneration of hepatocytes (bent arrow)Back to article page